Your browser doesn't support javascript.
loading
An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia.
Ko, Tun Kiat; Javed, Asif; Lee, Kian Leong; Pathiraja, Thushangi N; Liu, Xingliang; Malik, Simeen; Soh, Sheila Xinxuan; Heng, Xiu Ting; Takahashi, Naoto; Tan, Joanna H J; Bhatia, Ravi; Khng, Alexis J; Chng, Wee-Joo; Sia, Yee Yen; Fruman, David A; Ng, King Pan; Chan, Zhu En; Xie, Kim Jiajing; Hoi, Qiangze; Chan, Cheryl Xueli; Teo, Audrey S M; Velazquez Camacho, Oscar; Meah, Wee Yang; Khor, Chiea Chuen; Ong, Chin Thing J; Soon, Wei Jia W; Tan, Patrick; Ng, Pauline C; Chuah, Charles; Hillmer, Axel M; Ong, S Tiong.
Affiliation
  • Ko TK; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Javed A; Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore.
  • Lee KL; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Pathiraja TN; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Liu X; Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore.
  • Malik S; Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore.
  • Soh SX; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Heng XT; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Takahashi N; Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore.
  • Tan JHJ; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Bhatia R; Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore.
  • Khng AJ; Division of Hematology-Oncology, Department of Medicine, University of Alabama Birmingham, Birmingham, AL.
  • Chng WJ; Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore.
  • Sia YY; Department of Hematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore.
  • Fruman DA; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Ng KP; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Chan ZE; Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore.
  • Xie KJ; Department of Molecular Biology & Biochemistry, University of California, Irvine, CA.
  • Hoi Q; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Chan CX; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Teo ASM; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Velazquez Camacho O; Computational and Systems Biology, Genome Institute of Singapore, Singapore.
  • Meah WY; Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore.
  • Khor CC; Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore.
  • Ong CTJ; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Soon WJW; Human Genetics, Genome Institute of Singapore, Singapore.
  • Tan P; Human Genetics, Genome Institute of Singapore, Singapore.
  • Ng PC; Next Generation Sequencing Platform, Genome Institute of Singapore, Singapore.
  • Chuah C; Next Generation Sequencing Platform, Genome Institute of Singapore, Singapore.
  • Hillmer AM; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Ong ST; Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore.
Blood ; 135(26): 2337-2353, 2020 06 25.
Article in En | MEDLINE | ID: mdl-32157296
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Blast Crisis / Gene Expression Regulation, Leukemic / Polycomb Repressive Complex 1 / Polycomb Repressive Complex 2 Type of study: Prognostic_studies Limits: Humans Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Blast Crisis / Gene Expression Regulation, Leukemic / Polycomb Repressive Complex 1 / Polycomb Repressive Complex 2 Type of study: Prognostic_studies Limits: Humans Language: En Year: 2020 Type: Article